Products for Research Use Only
RegisterLogin

MMI-0100

CAT: 0804-HY-P3412-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P3412-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MMI-0100 is a cell-permeant peptide inhibitor of mitogen activated protein kinase activated protein kinase II (MK2) . MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. MMI-0100 suppresses IL-6 expression without effect on IL-8 expression. MMI-0100 suppresses fibrotic processes such as vein graft disease[1].
CAS Number
1039342-24-9
UNSPSC
12352209
Target
MAPKAPK2 (MK2)
Type
Peptides
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mmi-0100.html
Purity
98.83
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
OC(C=C1)=CC=C1C[C@H](N)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@@H](CCCCN)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](C(C)C)C(N[C@@H](C)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C98H171N37O26
Molecular Weight
2283.64
References & Citations
[1]Akihito Muto, et al. Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. Vascul Pharmacol. Jan-Feb 2012;56 (1-2) :47-55.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Scientific Category
Peptides
Clinical Information
Phase 1

Related Products

CatalogName
HY-157507JC-010a
HY-114239JBPOS-0101
HY-19347-01WDR5-0103
HY-151252-01NIC-0102
HY-148817-01WDR5-0102
HY-15237-01SL 0101-1
HY-113600H-0106 (dihydrochloride)
HY-127012H-0104 (dihydrochloride)
HY-172152MP-010
HY-129742JTT-010

Alternative Products

CatalogName
GTR19036325-01MMI-0100
GTR19031088MMI 0100
A22821-25MMI-0100 25mg
A22821-10MMI-0100 10mg
A22821-5MMI-0100 5mg
GTR19209949-01MMI-166
ZBE-0100-HP-BULKIOLILYTE ZBE 0100
LBE-0100-HP-BULKIOLILYTE LBE 0100
T131660-01Compound 0449-0100
GTR19227418-01Compound N105-0100

Popular Products